The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The transition towards electric vehicles (EVs) is quite literally, accelerating.
Hard numbers emerging from the automotive industry confirm this.
A Jato report found that European sales of EVs have now exceeded sales of diesel-engine vehicles for the first time.
For August 2021, EV sales gained their highest ever monthly market share of 21%. Diesel-engine vehicles saw a 20% market share.
Petrol vehicles made up 56% of sales. Although there’s still come catching up to do for EVs, the gap is quickly closing.
For example, in August 2020, monthly sales of petrol vehicles were five times higher than EV sales (58% to 11%).
September’s European EV sales will no doubt been influenced by the recent fuel crisis here in the UK.
In fact, according to carguide.co.uk, online searches for EVs in the UK rose 1,500% on 24 September 201, in comparison to the average daily search volume.
AutoTrader has already reported a “huge spike” in demand for EVs in light of this, which will likely spill over into October and beyond.
It’s a similar story across the Atlantic.
EV purchases have almost doubled in the United States since October.
This could be boosted further if US President Joe Biden reaches an agreement to pass a $3.5 trillion infrastructure deal, that would – in part – see the deployment of further EV infrastructure across the United States. Currently, negotiations are ongoing.
With demand for EVs clearly rising across the world, there isn’t a better time to get involved in the EV space.
Thank you.
Oh well… 1HKD not going to be hit.
Is this getting shorted?
Come on….. some news please..
When will we ever hit 1HKD!!!!!!!
Some large trades going on in black?
PRO finished, discussions ongoing with FDA, protocol power size calculated (given magnitude of effect, other phase III studies and real world experience doesn’t have to be large) sites identified, drug supply available, data now in Hispanics and African Americans, market size analysis and price point sensitivity re-done by top tier US marketing organisation, licensing partners have access to data room and have been updated.
With respect to 90s thinking, Pfizer Board just about fired me as total ED market ever was going to be $100mill. Definitely more than this in PE but not Viagra at $3.3billion pa. I was also developing Cardura for BPH although HQ felt there wasn’t such a condition. Only did $1.5 bill pay for 9 years,.
His comments seem like someone who knows the facts, from a good basic training but decides to twist them…….hallmarks of an employee “who has been let go” ? Could be licensor trying to knock the price down (joke).
Who is right or wrong will play out over the next 12-18 months. As I’m sure you appreciate as the information could be price sensitive I can only expand slightly beyond what is on the website. On that basis, until we are over the goal line I can’t answer and more bb questions……apologise to the guys please but at this stage lots of interested parties are trying to get information.
Our US consultants have implemented all of the recommended near-term strategies in the FDA guidance, including implementation of remote/video monitoring (which is ongoing at the moment). In fact, we implemented those strategies more than a week ago, before FDA provided guidance, and we think the monitoring staff are now comfortable with working this way. We have educated the CRAs on COVID-19 so they can interact with the sites effectively. Our US consultants have sent a letter to update the investigators. And the IRB has been updated on study status.
Our US consultant think we are far ahead of the curve on this issue and will continue to watch closely. However, if the FDA does recommend that sites be closed we will abide by their guidance but as yet we have not reached the state.
In respect of the TFDA, Oriental Europharma, our commercial partner in Taiwan is proceeding with its regulatory submission with the TFDA and in fact they sent us the recent feedback from the TFDA earlier this week. And also Fosun is liaising with the NMPA so the NMPA is shut down.
When we get FDA we will all be fine…..